107879 - Skin Cancer Clinical and Pathology Audit
Skin Cancer Clinical & Pathology Audit assists GPs in diagnosis and management of skin lesions. Audit reports containing peer analysis of procedure types, patient statistics, adequacy of excision and diagnostic concordance between the clinical diagnosis of skin tumours and their histopathological correlations will be issued on biannual basis. The analysis will educate GPs about their practice to help guide treatment options, the possible need for referral of some cases and aid in surgical planning via direct feedback. Significant discrepancy between their diagnoses and the histopathology or with the findings from their peers should prompt further education.
GPs must complete and submit evaluations for two consecutive quarterly feedbacks to complete a full audit activity and be eligible to receive 40 RACGP QI & CPT points.
Skin cancer is the most common type of cancer in the Australian adult population. The incidence of melanoma cancers increases with age with the mean age for diagnosis at 63 years and a low rate in less than 35 years of age. Non melanoma skin cancers such as basal cell and squamous cell carcinomas, account for 81% of all new cancer cases diagnosed in Australia. It is estimated that 65% of Australians will be diagnosed with skin cancer before the age of 70. Findings from the annual BEACH surveys of general practice conducted from 2006 to 2016 showed that skin cancer were consistently among the top ten conditions managed by GPs. This includes identification, medications, clinical and procedural treatments, tests, excision and biopsies of skin lesions, and ordering of pathology or imaging etc. Due to pathology services being remote to almost all GPs, Skin Cancer Clinical & Pathology Audit program formalizes feedback and interaction between pathologists and GPs.Learning outcomes